+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

A comparison study between GeXP-based multiplex-PCR and serology assay for Mycoplasma pneumoniae detection in children with community acquired pneumonia



A comparison study between GeXP-based multiplex-PCR and serology assay for Mycoplasma pneumoniae detection in children with community acquired pneumonia



Bmc Infectious Diseases 17(1): 518



Diagnosis of community-acquired pneumonia (CAP) caused by Mycoplasma pneumoniae (Mp) in children has been hampered by difficulty in obtaining convalescent serum and time constraints. In this study, the two diagnostic assays that targeted respectively on Mp-antibody and Mp-DNA were retrospectively investigated. A total of 3146 children were clinically diagnosed to have CAP and were confirmed by chest X-ray during March 2015 to February 2016 in Children's hospital of Hebei Province (China). Both of the sera and sputum samples were collected in 24 h after their admission. The Mp-antibody was examined by the passive particle agglutination assay and a fourfold or greater increase of antibody titers of paired sera or≧1:160 titer of single serum was set as the serology positive. Mp-DNA in the sputum samples was tested by a multiplex-PCR method named GeXP assay (multiplex PCR combined with automated capillary electrophoresis). In order to eliminate the false positive results caused by the asymptomatic carriage after infected by M. pneumoniae, the inconsistent samples were tested by the real-time isothermal transcription-mediated RNA amplification assay (SAT). The inter-rated agreement test was performed in 3146 CAP patients, with a highest kappa value in the school-age children as 0.783. There were 6.29% (198/3146) cases showed inconsistent results determined by GeXP and serology assay. All of the 19 GeXP(+)/Serology (-) samples and a randomly chosen 27 from 179 GeXP(-)/Serology (+) samples were tested by SAT assay, and a 97.8% diagnosis agreement was observed between SAT and GeXP assay, but not with the serology assay. In addition, patients who were detected only by serology or only by multiplex-PCR were significantly younger than those with both methods positive (3.0 and 1.5 years vs. 5.0 years, p < 0.01). The Viral-Mp coinfection accounted for 37.0% (97/262), which was more common in winter and spring (p < 0.05) and in the infantile group (p < 0.01), compared to the pure Mp positive ones. In some children CAP cases, the Mp laboratory diagnosis was inconsistent between serology and multiplex-PCR assay. Verified by the SAT assay, the GeXP showed a more sensitive and reliable performance compared with the serology assay. Furthermore, employing the multiplex-PCR could provide more information on the associated pathogens for clinical assessment of CAP.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 059313364

Download citation: RISBibTeXText

PMID: 28743259

DOI: 10.1186/s12879-017-2614-3


Related references

Detection of Mycoplasma pneumoniae by loop-mediated isothermal amplification (LAMP) assay and serology in pediatric community-acquired pneumonia. Journal of Infection and ChemoTherapy 18(5): 662-667, 2012

A GeXP-Based Assay for Simultaneous Detection of Multiple Viruses in Hospitalized Children with Community Acquired Pneumonia. Plos one 11(9): E0162411, 2016

Detection of Mycoplasma pneumoniae in adult community-acquired pneumonia by PCR and serology. Journal of Medical Microbiology 57(Pt 12): 1491-1495, 2008

Multiplex PCR for the simultaneous detection of Chlamydia pneumoniae, Mycoplasma pneumoniae and Legionella pneumophila in community-acquired pneumonia. Respiratory Medicine 98(6): 542-550, 2004

Evaluation of diagnosis of atypical pneumonia by multiplex PCR-based assay Simultaneous detection of Legionella -pneumophila, Chlamydia pneumoniae, and Mycoplasma pneumoniae in clinical samples from patients with pneumonia. Abstracts of the General Meeting of the American Society for Microbiology 102: 144, 2002

Application of PCR for Mycoplasma pneumoniae detection in children with community-acquired pneumonia. Journal of Infection and ChemoTherapy 10(5): 274-279, 2005

Incidence of community-acquired pneumonia in children caused by Mycoplasma pneumoniae: serological results of a prospective, population-based study in primary health care. Respirology 9(1): 109-114, 2004

Detection of Mycoplasma pneumoniae in Mexican children with community-acquired pneumonia: experience in a tertiary care hospital. Infection and Drug Resistance 12: 925-935, 2019

Comparison of a multiplex PCR-based assay and culture for the detection of Mycoplasma pneumoniae in seeded pleural fluid specimens. Abstracts of the General Meeting of the American Society for Microbiology 96: 31, 1996

Diagnostic utility and clinical significance of naso- and oropharyngeal samples used in a PCR assay to diagnose Mycoplasma pneumoniae infection in children with community-acquired pneumonia. Journal of Clinical Microbiology 42(7): 3339-3341, 2004

Detection of Mycoplasma pneumoniae and Chlamydophila pneumoniae in patients with community acquired pneumonia. Zhurnal Mikrobiologii, Epidemiologii, i Immunobiologii: 65-67, 2005

Prevalence of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community acquired pneumonia. Indian Journal of Pediatrics 65(5): 717-721, 1998

Mycoplasma pneumoniae and Chlamydophila pneumoniae in children with community-acquired pneumonia in Thailand. International Journal of Tuberculosis and Lung Disease 11(7): 814-819, 2007

Importance of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community-acquired pneumonia. Revista Medica de Panama 23(2): 27-33, 1998

Chlamydia pneumoniae and Mycoplasma pneumoniae in young children from China with community-acquired pneumonia. Diagnostic Microbiology and Infectious Disease 52(1): 7-14, 2005